Vallon Pharmaceuticals, Inc. | Business Contracts

A&R 2018 Equity Incentive Plan (Filed With SEC on May 15, 2023)

Separation Agreement, dated April 21, 2023, by and between GRI Bio, Inc. and David Baker (Filed With SEC on April 21, 2023)

Amended and Restated GRI Bio, Inc. 2018 Equity Incentive Plan (Filed With SEC on April 21, 2023)

Consulting Agreement, by and between GRI Bio, Inc. and Albert Agro, M.D., dated as of January 9, 2023 (Filed With SEC on April 21, 2023)

Form of Indemnification Agreement (Filed With SEC on April 21, 2023)

Form of Ecoban Warrant (Filed With SEC on April 21, 2023)

Omnibus Amendment to Securities Purchase Agreements, dated February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc. and the investor party thereto (Filed With SEC on February 24, 2023)

Amendment to Agreement and Plan of Merger, dated as of February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc., and Vallon Merger Sub, Inc (Filed With SEC on February 24, 2023)

Restricted Stock Purchase Agreement, by and between GRI Bio, Inc. and Albert Agro, dated as of November 1 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to TEP Biotech, LLC, dated as of November 2, 2018 (Filed With SEC on December 23, 2022)

Nonqualified Stock Option Agreement by and between GRI Bio, Inc. and Gerald Yakatan, dated as of November 4 (Filed With SEC on December 23, 2022)

Nonqualified Stock Option Agreement by and between GRI Bio, Inc. and Rohit Loomba, dated as of November 4 (Filed With SEC on December 23, 2022)

Incentive Stock Option Agreement by and between GRI Bio, Inc. and Sean Edwards, dated as of November 4 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to FT618 Investments, LLC, dated as of December 28, 2020 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to FT618 Investments, LLC, dated as of November 9, 2020 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to Eric Reiter, dated as of November 4, 2020 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to Dinver LLC, dated as of November 4, 2020 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to Oppel Greeff, dated as of November 4, 2020 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to Oppel Greeff, dated as of July 7, 2022 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to TEP Biotech, LLC, dated as of July 7, 2022 (Filed With SEC on December 23, 2022)

Warrant to Purchase Stock issued to TEP Biotech, LLC, dated as of December 3, 2019 (Filed With SEC on December 23, 2022)

Form of Senior Secured Note of GRI Bio, Inc (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Albert Agro, dated as of April 2, 2015, as amended by the Amendment to the Restricted Stock Award Agreement, by... (Filed With SEC on December 23, 2022)

Restricted Stock Purchase Agreement, by and between GRI Bio, Inc. and Vipin Kumar Chaturvedi, dated as of March 28 (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Vipin Kumar Chaturvedi, dated as of April 2, 2015, as amended by the Amendment to the Restricted Stock Award... (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Sean Edwards, dated as of March 31 (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Sean Edwards, dated as of December (Filed With SEC on December 23, 2022)

Restricted Stock Purchase Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of March 28 (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of April 2, 2015, as amended by the Amendment to the Restricted Stock Award Agreement,... (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of March 31 (Filed With SEC on December 23, 2022)

Restricted Stock Award Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of December (Filed With SEC on December 23, 2022)

Consulting and Clinical Advisory Board Agreement, by and between GRI Bio, Inc. and Rohit Loomba, M.D., dated as of June 3 (Filed With SEC on December 23, 2022)

Consulting and Scientific Advisory Board Agreement, by and between GRI Bio, Inc. and Vipin Kumar Chaturvedi, personally or through Vidur Discoveries LLC, dated as of October 31 (Filed With SEC on December 23, 2022)

Lease Agreement, dated as of March 2, 2018, by and between La Jolla Shores Plaza, LLC and GRI Bio, Inc., for that property located at 2223 Avenida de la Playa, Suite 208, La... (Filed With SEC on December 23, 2022)

GRI Bio, Inc. 2015 Equity Incentive (Filed With SEC on December 23, 2022)

Stock Redemption Agreement, by and between GRI Bio, Inc. and Catalent Ontario Limited, dated as of November 2 (Filed With SEC on December 23, 2022)

Non-Employee Director Compensation Program of Vallon Pharmaceuticals, Inc., effective on June 9, 2022 (Filed With SEC on July 28, 2022)

Form of Amendment No. 1 to Common Stock Purchase Warrant (Filed With SEC on July 26, 2022)

Amendment No. 1 to Securities Purchase Agreement dated July 25, 2022 (Filed With SEC on July 26, 2022)

Form of Securities Purchase Agreement (Filed With SEC on May 13, 2022)

Placement Agency Agreement, dated May 13, 2022, between the Company and Ladenburg Thalmann & Co., Inc (Filed With SEC on May 13, 2022)

Form of Warrant (Filed With SEC on May 13, 2022)

Employment Agreement, dated as of May 10, 2021, by and between the Company and Leanne M. Kelly (Filed With SEC on May 13, 2021)

Employment Agreement, dated as of April 20, 2021, by and between the Company and David Baker (Filed With SEC on May 13, 2021)

Description of the securities of Vallon Pharmaceuticals, Inc. registered under Section 12 of the Exchange Act (Filed With SEC on March 29, 2021)

Underwriting Agreement, dated February 9, 2021, between the Company and ThinkEquity, a division of Fordham Financial Management, Inc (Filed With SEC on February 16, 2021)

Form of Representatives Warrant (Filed With SEC on February 16, 2021)

Form of Underwriter Warrant (Filed With SEC on January 28, 2021)

Specimen certificate evidencing shares of common stock (Filed With SEC on January 28, 2021)

Form of Underwriting Agreement (Filed With SEC on January 28, 2021)

Voting Agreement, dated as of December 30, 2020, by and among Vallon Pharmaceuticals, Inc (Filed With SEC on January 14, 2021)

Amended and Restated Asset Purchase Agreement, dated as of June 22, 2017, by and among Arcturus Therapeutics, Ltd. (and its subsidiary, Arcturus Therapeutics, Inc.), Amiservice... (Filed With SEC on January 14, 2021)

Consulting Agreement with Whitaker Biopharmaceutical Consulting LLC, dated April 2, 2018 (Filed With SEC on January 14, 2021)

Employment Agreement between Vallon Pharmaceuticals, Inc. and Penny S. Toren, dated April 2, 2018 (Filed With SEC on January 14, 2021)

Employment Agreement between Vallon Pharmaceuticals, Inc. and David Baker, dated January 15, 2019 (Filed With SEC on January 14, 2021)

Form of Nonqualified Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on January 14, 2021)

Form of Directors and Officers Indemnity Agreement (Filed With SEC on January 14, 2021)

Patent and Patent Application Assignment Agreement between Arcturus Therapeutics, Ltd. and Vallon Pharmaceuticals, Inc., dated June 22, 2018 (Filed With SEC on January 14, 2021)

Form of Subscription Agreement (Filed With SEC on January 14, 2021)

Form of Stock Purchase Agreement, dated June 7, 2018, among Vallon Pharmaceuticals, Inc. and the investors listed therein (Filed With SEC on January 14, 2021)

Form of Stock Purchase Agreement, dated July 25, 2019, between Vallon Pharmaceuticals, Inc (Filed With SEC on January 14, 2021)

Investors Rights Agreement, dated as of July 25, 2019, by and between Vallon Pharmaceuticals, Inc. and Salmon Pharma GmbH (Filed With SEC on January 14, 2021)

Form of Lock Up Agreement (Filed With SEC on January 14, 2021)

Form of Convertible Promissory Note Purchase Agreement, dated as of January 11, 2021, by and among Vallon Pharmaceuticals and the investors named therein (Filed With SEC on January 14, 2021)

Form of Convertible Promissory Note (Filed With SEC on January 14, 2021)

License Agreement, effective as of January 6, 2020, by and between Vallon Pharmaceuticals, Inc. and MEDICE Arzneimittel Putter GmbH & Co. KG (Filed With SEC on November 16, 2020)

Convertible Promissory Note Purchase Agreement, dated as of April 11, 2019 (Filed With SEC on October 23, 2020)

Form of Incentive Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)

Form of Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)

Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)

Form of Convertible Promissory Note (Filed With SEC on October 23, 2020)

Vallon Pharmaceuticals, Inc. (71)